Multiple contemporary studies involving  single center and multi center experience suggests an overall lifetime<unk>  of<unk>  thrombosis is 0.5 % - 2.5 %.    There is some variation of these numbers with the definitions used. For instance, in a recent study of 8847 patients who received a BMS, a cumulative<unk>  of definite, probable or possible<unk>  thrombosis (ST) over 15 months was 2.15% and that for definite ST was 0.61%. In a study involving serial angiography after sirolimus-eluting<unk>  (SES) and BMS implantation at 4, 11, and 21.2 ± 2.2 months, no BMS developed thrombus, however SES demonstrated the presence of thrombi and yellow plaques even as much as 2 years after implantation.
Stent thrombosis incidence in bare metal stents
Stent thrombosis Relation to drug eluting stents
Chronic stable angina prognosis
Spontaneous coronary artery dissection treatment approach
Endocarditis surgical indications
ST elevation myocardial infarction pathophysiology
D-dimer prognostic role in mortality
Non ST elevation myocardial infarction pathophysiology